C07D 203/10
Radicals substituted by singly bound oxygen atoms
C07D203/10 (Radicals substituted by singly bound oxygen atoms) appears on 60 US grants and 47 published applications in this corpus.
Search patents in C07D- Granted patents
- 60
- Published applications
- 47
- Assignees
- 36
- Inventors
- 151
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 2 | 0 |
| 1978 | 4 | 0 |
| 1979 | 3 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 1 | 0 |
| 2010 | 1 | 2 |
| 2011 | 0 | 2 |
| 2012 | 0 | 4 |
| 2013 | 0 | 2 |
| 2014 | 1 | 0 |
| 2015 | 4 | 3 |
| 2016 | 2 | 2 |
| 2017 | 4 | 1 |
| 2018 | 2 | 5 |
| 2019 | 1 | 2 |
| 2020 | 2 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 2 |
| 2023 | 1 | 13 |
| 2024 | 1 | 3 |
| 2025 | 10 | 1 |
| 2026 | 2 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Aziridinyl functional compound26 May 2026US 12,637,423 B2Covestro (Netherlands) B.V.
- Coating composition3 Mar 2026US 12,565,473 B2Covestro (Netherlands) B.V.
- Aziridine functional compound23 Dec 2025US 12,503,435 B2Covestro (Netherlands) B.V.
- Lipids and compositions for the delivery of therapeutics28 Oct 2025US 12,453,776 B2Arbutus Biopharma Corporation
- Waterborne crosslinker composition26 Aug 2025US 12,398,098 B2Covestro (Netherlands) B.V.
- Novel lipids and compositions for the delivery of therapeutics13 Aug 2026US 2026/0232810 A1Arbutus Biopharma Corporation
- Synthesis of ras inhibitors10 Apr 2025US 2025/0115551 A1Revolution Medicines, Inc.
- Novel lipids and compositions for the delivery of therapeutics26 Dec 2024US 2024/0424105 A1Arbutus Biopharma Corporation
- N-heterocyclyl substituted 2-cyano-3-(naphthalen-2-yl)acrylamide derivatives as fluorophors for detection of amyloid and amyloid-like proteins for diagnosis of neurodegenerative disorders3 Oct 2024US 2024/0325572 A1Amydis, Inc.
- Lipids and compositions for the delivery of therapeutics8 Feb 2024US 2024/0042039 A1Arbutus Biopharma Corporation
Most cited
By later US patents
- Lipids and compositions for the delivery of therapeutics102US 8,999,351 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics101US 9,186,325 B2Tekmira Pharmaceuticals Corporation · 2015
- Lipids and compositions for the delivery of therapeutics30US 9,682,139 B2Arbutus Biopharma Corporation · 2017
- Aziridine-functional photoactive crosslinking compounds28US 7,838,110 B23M Innovative Properties Company · 2010
- Lipids and compositions for the delivery of therapeutics28US 9,220,683 B2Tekmira Pharmaceuticals Corporation · 2015